...
search icon
allr-img

Allarity Therapeutics Inc, Common Stock

ALLR

NAQ

$1.03

-$0.03

(-2.82%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$15.68M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0.0016
Volume info-icon
This is the total number of shares traded during the most recent trading day.
344.18K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.15
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.61 L
$20.44 H
$1.03

About Allarity Therapeutics Inc, Common Stock

Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing novel anti-cancer therapeutics for patients with unmet medical needs. The company develops drugs for the personalized treatment of cancer using drug specific companion diagnostics generated by its proprietary drug response predictor technology. Its lead drug candidate includes Stenoparib, a novel dual inhibitor of poly-ADP-ribose polymerase (PARP1/2) that is being evaluated in a phase 2 clinical trial in patients with advanced and recurrent ovarian cancer. The company also develops stenoparib- DRP, a companion diagnostic product used in select patients for stenoparib treatment. Allarity Therapeutics, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameALLRSectorS&P500
1-Week Return-0.96%-1.91%-1.87%
1-Month Return1.98%-3.82%8.93%
3-Month Return25.59%-11.56%-2.39%
6-Month Return-19.53%-10.21%-2.41%
1-Year Return-94.27%-9.91%10.88%
3-Year Return-100%-0.28%46.93%
5-Year Return-100%31.29%94.89%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue86.00K106.00K120.00K37.00K-[{"date":"2020-12-31","value":71.67,"profit":true},{"date":"2021-12-31","value":88.33,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":30.83,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit(86.00K)(106.00K)(120.00K)(37.00K)-[{"date":"2020-12-31","value":-8600000,"profit":false},{"date":"2021-12-31","value":-10600000,"profit":false},{"date":"2022-12-31","value":-12000000,"profit":false},{"date":"2023-12-31","value":-3700000,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin(Infinity%)(Infinity%)(Infinity%)(Infinity%)-[{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses9.23M26.56M16.89M17.89M17.54M[{"date":"2020-12-31","value":34.75,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":63.61,"profit":true},{"date":"2023-12-31","value":67.37,"profit":true},{"date":"2024-12-31","value":66.04,"profit":true}]
Operating Income(9.23M)(26.56M)(34.46M)(17.93M)(27.24M)[{"date":"2020-12-31","value":-922700000,"profit":false},{"date":"2021-12-31","value":-2655600000,"profit":false},{"date":"2022-12-31","value":-3446300000,"profit":false},{"date":"2023-12-31","value":-1792900000,"profit":false},{"date":"2024-12-31","value":-2724100000,"profit":false}]
Total Non-Operating Income/Expense1.67M(1.80M)(880.00K)4.96M2.23M[{"date":"2020-12-31","value":33.75,"profit":true},{"date":"2021-12-31","value":-36.41,"profit":false},{"date":"2022-12-31","value":-17.75,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":44.89,"profit":true}]
Pre-Tax Income(7.23M)(26.52M)(17.58M)(12.62M)(24.90M)[{"date":"2020-12-31","value":-723400000,"profit":false},{"date":"2021-12-31","value":-2651500000,"profit":false},{"date":"2022-12-31","value":-1757900000,"profit":false},{"date":"2023-12-31","value":-1261800000,"profit":false},{"date":"2024-12-31","value":-2489600000,"profit":false}]
Income Taxes(2.16M)133.00K(1.52M)(717.00K)(381.00K)[{"date":"2020-12-31","value":-1624.81,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-1143.61,"profit":false},{"date":"2023-12-31","value":-539.1,"profit":false},{"date":"2024-12-31","value":-286.47,"profit":false}]
Income After Taxes(5.07M)(26.65M)(16.06M)(11.90M)(24.52M)[{"date":"2020-12-31","value":-507300000,"profit":false},{"date":"2021-12-31","value":-2664800000,"profit":false},{"date":"2022-12-31","value":-1605800000,"profit":false},{"date":"2023-12-31","value":-1190100000,"profit":false},{"date":"2024-12-31","value":-2451500000,"profit":false}]
Income From Continuous Operations(5.07M)(26.65M)(16.06M)(13.02M)(24.52M)[{"date":"2020-12-31","value":-507300000,"profit":false},{"date":"2021-12-31","value":-2664800000,"profit":false},{"date":"2022-12-31","value":-1605800000,"profit":false},{"date":"2023-12-31","value":-1301700000,"profit":false},{"date":"2024-12-31","value":-2451500000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(5.07M)(26.65M)(16.06M)(11.90M)(24.52M)[{"date":"2020-12-31","value":-507300000,"profit":false},{"date":"2021-12-31","value":-2664800000,"profit":false},{"date":"2022-12-31","value":-1605800000,"profit":false},{"date":"2023-12-31","value":-1190100000,"profit":false},{"date":"2024-12-31","value":-2451500000,"profit":false}]
EPS (Diluted)(0.04)(1.00M)(18.53)(29.23)-[{"date":"2020-12-31","value":-4.08,"profit":false},{"date":"2021-12-31","value":-100000101.68,"profit":false},{"date":"2022-12-31","value":-1853,"profit":false},{"date":"2023-12-31","value":-2923,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ALLR
Cash Ratio 2.28
Current Ratio 2.66

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ALLR
ROA (LTM) -48.96%
ROE (LTM) -383.74%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ALLR
Debt Ratio Lower is generally better. Negative is bad. 0.37
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.63

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ALLR
Trailing PE 0.00
Forward PE NM
P/S (TTM) 0.00
P/B 0.83
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Allarity Therapeutics Inc share price today?

Allarity Therapeutics Inc (ALLR) share price today is $1.03

Can Indians buy Allarity Therapeutics Inc shares?

Yes, Indians can buy shares of Allarity Therapeutics Inc (ALLR) on Vested. To buy Allarity Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ALLR stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Allarity Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Allarity Therapeutics Inc (ALLR) via the Vested app. You can start investing in Allarity Therapeutics Inc (ALLR) with a minimum investment of $1.

How to invest in Allarity Therapeutics Inc shares from India?

You can invest in shares of Allarity Therapeutics Inc (ALLR) via Vested in three simple steps:

  • Click on Sign Up or Invest in ALLR stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Allarity Therapeutics Inc shares
What is Allarity Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Allarity Therapeutics Inc (ALLR) is $20.44. The 52-week low price of Allarity Therapeutics Inc (ALLR) is $0.61.

What is Allarity Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Allarity Therapeutics Inc (ALLR) is 0.0016

What is Allarity Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Allarity Therapeutics Inc (ALLR) is 0.83

What is the Market Cap of Allarity Therapeutics Inc?

The market capitalization of Allarity Therapeutics Inc (ALLR) is $15.68M

What is Allarity Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Allarity Therapeutics Inc is ALLR

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top